Inquire Before Buying
Speak to an Analyst 
Request Brochure 
Request CustomizationIMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
Read More
US Generic Drug Market Report by Segment (Unbranded, Branded), Therapy Area (CNS, Cardiovascular, Dermatology, Genitourinary/Hormonal, Respiratory, Rheumatology, Diabetes, Oncology, and Others), Drug Delivery (Oral, Injectables, Dermal/Topical, Inhalers), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) 2024-2032
Report Format: PDF+Excel | Report ID: SR112024A567
Buy Now
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 US Generic Drug Market - Introduction
4.1 What are Generic Drugs
4.2 Unbranded and Branded Generics
4.3 Authorized Generics
4.4 Commoditized and Specialty Generics
5 Why is the US Generic Drug Market So Lucrative
5.1 Patent Expiry of Blockbuster Drugs
5.2 Significant Price Differential between Generics and Innovator Drugs
5.3 Savings for the Government and Third-Party Payers
5.4 Incentives for Dispensing and Prescribing Generic Drugs
5.5 Reimbursement and Lower Co-payments
5.6 Biosimilars
6 Global Generic Drug Market
6.1 Market Performance
6.1.1 Volume Trends
6.1.2 Value Trends
6.2 Market Breakup by Country
6.3 Market Forecast
6.4 Most Prescribed Generic and Branded Drugs
7 US Generic Drug Market
7.1 US Pharmaceutical Market Performance
7.1.1 Volume Trends
7.1.2 Value Trends
7.1.3 Market Breakup by Type
7.1.4 Market Forecast
7.2 US Generic Drug Market Performance
7.2.1 Volume Trends
7.2.2 Value Trends
7.2.3 Impact of COVID-19
7.2.4 Market Breakup by Segment
7.2.5 Market Breakup by Therapy Area
7.2.6 Market Breakup by Drug Delivery
7.2.7 Market Breakup by Distribution Channel
7.2.8 Market Forecast
8 Market Breakup by Segment
8.1 Unbranded Generics
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Branded Generics
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by Therapy Area
9.1 CNS
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Cardiovascular
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Dermatology
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Genitourinary/Hormonal
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Respiratory
9.5.1 Market Trends
9.5.2 Market Forecast
9.6 Rheumatology
9.6.1 Market Trends
9.6.2 Market Forecast
9.7 Diabetes
9.7.1 Market Trends
9.7.2 Market Forecast
9.8 Oncology
9.8.1 Market Trends
9.8.2 Market Forecast
9.9 Others
9.9.1 Market Trends
9.9.2 Market Forecast
10 Market Breakup by Drug Delivery
10.1 Oral
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Injectables
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Dermal/Topical
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Inhalers
10.4.1 Market Trends
10.4.2 Market Forecast
11 Market Breakup by Distribution Channel
11.1 Retail Pharmacies
11.1.1 Market Trends
11.1.2 Market Forecast
11.2 Hospital Pharmacies
11.2.1 Market Trends
11.2.2 Market Forecast
12 US Generic Drug Market - SWOT Analysis
12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats
13 US Generic Drug Market - Value Chain Analysis
13.1 Research and Development
13.2 Raw Material Procurement
13.3 Manufacturing
13.4 Marketing
13.5 Distribution
13.6 End-Consumer
14 Pricing Mechanism and Profit Margins at Various Levels of the Supply Chain
15 Porter’s Five Forces Analysis
15.1 Overview
15.2 Bargaining Power of Buyers
15.3 Bargaining Power of Suppliers
15.4 Degree of Rivalry
15.5 Threat of New Entrants
15.6 Threat of Substitutes
16 US Generic Drug Market- Competitive Landscape
16.1 US Generic Drug Market - Competitive Structure
16.2 US Generic Drug Market - Breakup of Key Players
16.3 US Generic Drug Market - Most Prescribed Generic Drugs
16.4 US Generic Drug Market - Market Breakup by Distribution
16.5 US Generic Drug Market - Pricing Dynamics
17 Regulations in the US Generic Drug Industry
17.1 Overview of Pharmaceutical Regulations
17.2 Drug Applications
17.3 Patents and Market Exclusivity
17.4 Regulatory Requirements for Generic Drugs
17.5 The Hatch-Waxman Act
17.6 Certifications
17.7 Other Important Considerations
18 US Generic Drug Market: Key Success Factors
19 US Generic Drug Market: Road Blocks
20 Requirements for Setting Up a Generic Drug Manufacturing Plant
20.1 Manufacturing Process
20.2 Raw Material Requirements
20.3 Raw Materials Pictures
20.4 Land and Construction Requirements
20.5 Machinery and Infrastructure Requirements
20.6 Machinery Pictures
20.7 Plant Layout
20.8 Packaging Requirements
20.9 Utility Requirements
20.10 Manpower Requirements
21 US Generic Drug Market - Key Company Profiles
21.1 Teva
21.2 Mylan
21.3 Actavis (Teva)
21.4 Sandoz (Novartis)
21.5 Sun Pharma
21.6 Par Pharmaceuticals (Endo Pharmaceuticals)
21.7 Lupin Pharmaceuticals
21.8 Dr Reddy’s
21.9 Hospira (Pfizer)
List of Figures
Figure 1: Structure of the Pharmaceutical Industry
Figure 2: Classification of Generic Drugs
Figure 3: US: Patent Expiry Exposure (in Billion US$), 2018-2023
Figure 4: US: Savings from Generic Drugs (in Billion US$), 2018-2023
Figure 5: Global: Generic Drug Market: Sales Value (in Billion US$), 2018-2023
Figure 6: Global: Generic Drug Market: Sales Volume (in Billion Standards Units), 2018-2023
Figure 7: Global: Generic Drug Market: Sales Value Breakup by Country (in %), 2023
Figure 8: Global: Generic Drug Market: Sales Volume Breakup by Country (in %), 2023
Figure 9: Global: Generic Drug Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 10: Global: Generic Drug Market Forecast: Sales Volume (in Billion Standards Units), 2024-2032
Figure 11: US: Pharmaceutical Market: Sales Volume (in Million Prescriptions), 2018-2023
Figure 12: US: Pharmaceutical Market: Sales Value (in Billion US$), 2018-2023
Figure 13: US: Pharmaceutical Market: Sales Volume Breakup of Branded and Generic Drugs (in %), 2018 & 2023
Figure 14: US: Pharmaceutical Market: Sales Value Breakup of Branded and Generic Drugs (in %), 2018 & 2023
Figure 15: US: Pharmaceutical Market Forecast: Sales Volume (in Million Prescriptions), 2024-2032
Figure 16: US: Pharmaceutical Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 17: US: Generic Drug Market: Sales Volume (in Million Prescriptions), 2018-2023
Figure 18: US: Generic Drug Market: Sales Value (in Billion US$), 2018-2023
Figure 19: US: Generic Drug Market: Breakup by Segment (in %), 2023
Figure 20: US: Generic Drug Market: Breakup by Therapy Area (in %), 2023
Figure 21: US: Generic Drug Market: Breakup by Drug Delivery (in %), 2023
Figure 22: US: Generic Drug Market: Breakup by Distribution Channel (in %), 2023
Figure 23: US: Generic Drug Market Forecast: Sales Volume (in Million Prescriptions), 2024-2032
Figure 24: US: Generic Drug Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 25: Generic Drug Market: Price Structure
Figure 26: US: Generic Drug Industry: SWOT Analysis
Figure 27: US: Generic Drug Industry: Value Chain Analysis
Figure 28: US: Generic Drug Industry: Pricing Mechanism and Profit Margins at the Various Levels of the Supply Chain
Figure 29: US: Generic Drug Industry: Porter's Five Forces Analysis
Figure 30: US: Generic Drug Market: Unbranded Generics (in Million Prescriptions), 2018 & 2023
Figure 31: US: Generic Drug Market Forecast: Unbranded Generics (in Million Prescriptions), 2024-2032
Figure 32: US: Generic Drug Market: Branded Generics (in Million Prescriptions), 2018 & 2023
Figure 33: US: Generic Drug Market Forecast: Branded Generics (in Million Prescriptions), 2024-2032
Figure 34: US: Generic Drug Market: CNS (in Million US$), 2018 & 2023
Figure 35: US: Generic Drug Market Forecast: CNS (in Million US$), 2024-2032
Figure 36: US: Generic Drug Market: Cardiovascular (in Million US$), 2018 & 2023
Figure 37: US: Generic Drug Market Forecast: Cardiovascular (in Million US$), 2024-2032
Figure 38: US: Generic Drug Market: Dermatology (in Million US$), 2018 & 2023
Figure 39: US: Generic Drug Market Forecast: Dermatology (in Million US$), 2024-2032
Figure 40: US: Generic Drug Market: Genitourinary/Hormonal (in Million US$), 2018 & 2023
Figure 41: US: Generic Drug Market Forecast: Genitourinary/Hormonal (in Million US$), 2024-2032
Figure 42: US: Generic Drug Market: Respiratory (in Million US$), 2018 & 2023
Figure 43: US: Generic Drug Market Forecast: Respiratory (in Million US$), 2024-2032
Figure 44: US: Generic Drug Market: Rheumatology (in Million US$), 2018 & 2023
Figure 45: US: Generic Drug Market Forecast: Rheumatology (in Million US$), 2024-2032
Figure 46: US: Generic Drug Market: Diabetes (in Million US$), 2018 & 2023
Figure 47: US: Generic Drug Market Forecast: Diabetes (in Million US$), 2024-2032
Figure 48: US: Generic Drug Market: Oncology (in Million US$), 2018 & 2023
Figure 49: US: Generic Drug Market Forecast: Oncology (in Million US$), 2024-2032
Figure 50: US: Generic Drug Market: Others (in Million US$), 2018 & 2023
Figure 51: US: Generic Drug Market Forecast: Others (in Million US$), 2024-2032
Figure 52: US: Generic Drug Market: Oral (in Million US$), 2018 & 2023
Figure 53: US: Generic Drug Market Forecast: Oral (in Million US$), 2024-2032
Figure 54: US: Generic Drug Market: Injectables (in Million US$), 2018 & 2023
Figure 55: US: Generic Drug Market Forecast: Injectables (in Million US$), 2024-2032
Figure 56: US: Generic Drug Market: Dermal/Topical (in Million US$), 2018 & 2023
Figure 57: US: Generic Drug Market Forecast: Dermal/Topical (in Million US$), 2024-2032
Figure 58: US: Generic Drug Market: Inhalers (in Million US$), 2018 & 2023
Figure 59: US: Generic Drug Market Forecast: Inhalers (in Million US$), 2024-2032
Figure 60: US: Generic Drug Market: Retail Pharmacies (in Million US$), 2018 & 2023
Figure 61: US: Generic Drug Market Forecast: Retail Pharmacies (in Million US$), 2024-2032
Figure 62: US: Generic Drug Market: Hospital Pharmacies (in Million US$), 2018 & 2023
Figure 63: US: Generic Drug Market Forecast: Hospital Pharmacies (in Million US$), 2024-2032
Figure 64: US: Generic Drug Market: Sales Breakup of Top Players (in %)
Figure 65: US: Generic Drug Market: Volume Share of Top Players (in %)
Figure 66: US: Generic Drug Market: Volume Share by Distribution (in %)
Figure 67: US: Generic Drug Prices as a Percentage of Branded Drug Prices – Based on Number of Competitors
Figure 68: US: Generic Drug Market: Detailed Process Flow
Figure 69: US: Generic Drug Market: Raw Material Requirements
Figure 70: US: Generic Drug Market: Plant Layout
Figure 71: US: Generic Drug Market: Packaging Requirements
List of Tables
Table 1: US: Sales and Patent Expiry of Major Drugs Expected to Lose Patent Protection (in Billion US$)
Table 2: US: Expenses of Generic and Branded Drug Manufacturers (in %)
Table 3: Global: Generic Drug Market: Volume Performance of Top Generic Drugs (in Million Prescriptions)
Table 4: Global: Branded Drug Market: Volume Performance of Top Branded Drugs (in Million Prescriptions)
Table 5: US: Generic Drug Market: Sales Performance of Top Players (in Billion US$), 2023
Table 6: US: Generic Drug Market: Volume Performance of Top Players (in Billion Units), 2023
Table 7: US: Generics Market: Volume Performance of Top Generic Drugs (in Million Prescriptions), 2023
Table 8: US: Overview of Pharmaceutical Regulations
Table 9: US: Generic Drug Market: Land and Construction Requirements
Table 10: US: Generic Drug Market: Machinery and Infrastructure Requirements
Table 11: US: Generic Drug Market: Utility Requirements
Table 12: US: Generic Drug Market: Manpower Requirements
Purchase options
Benefits of Customization
Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-631-791-1145
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-713-2163
Email: sales@imarcgroup.com
Client Testimonials
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
Read More
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
Read More
Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.
Read More.webp)
We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.
Read More
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
Read More
The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.
Read More
My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.
Read More
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
Read More.webp){kind=logo}
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.
Read More
IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.
Read More